CSRxP Applauds Secretary Azar’s Focus on List Prices
CSRxP spokesman Will Holley released the following statement in response to… Read More
© 2026 CSRXP- All Rights Reserved
CSRxP Testimony for the Record: Senate Finance Committee Hearing on Rx Prices
The Campaign for Sustainable Rx Pricing today released testimony for the… Read More
CSRxP Applauds Senate Judiciary Committee for Vote on CREATES Act
“We applaud the members of the Senate Judiciary Committee for voting the… Read More
CSRxP Statement on Secretary Azar’s Testimony in Front of Senate HELP Committee
“When the manufacturer-set price of a drug starts out high… Read More
46 Signatories Applaud Grassley & Feinstein for CREATES Act Markup
46 organizations today applauded Chairman Chuck Grassley and Ranking Member… Read More
CSRxP Statement on HHS OIG Part D Spending Report
Today, the Office of the Inspector General at the Department of Health and… Read More
CSRxP Applauds FDA’s Focus on REMS Abuses
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP Applauds FDA’s Transparency on Brand “Gaming” Tactics
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP on President Trump’s Remarks on Drug Prices
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP Launches TV & Digital Ad Campaign Urging Congress to Pass the CREATES Act
March 8, 2018 Contact: [email protected] ( 202) 286-4682 The Campaign for… Read More
CSRxP Statement on Nomination of Alex Azar to be Secretary of Health and Human Services
The Campaign for Sustainable Rx Pricing released the following statement… Read More
Vizient Joins CSRxP as 30th Member of the Coalition
“We are excited to join CSRxP and be a part of the coalition to achieve reasonable prescription drug prices,” says Jody Hatcher, president, sourcing and collaboration services at Vizient. “Our health care members are facing enormous financial and clinical pressures associated with pharmaceuticals. Read More